ArticleFrontiers in medicine2026
Evaluation of extracorporeal membrane oxygenation in children with acute hypoxemic respiratory failure and hemodynamic instability in China: a 7-year single-center retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To characterize the clinical features, laboratory parameters, and outcomes of pediatric patients with acute hypoxemic respiratory failure (AHRF) and concurrent hemodynamic instability requiring extracorporeal membrane oxygenation (ECMO), and to identify risk factors associated with mortality. Methods: This retrospective study was conducted in the Pediatric Intensive Care Unit (PICU) of the Children's Hospital of Fudan University, China. We enrolled patients aged 28 days-18 years with AHRF and hemodynamic instability despite mechanical ventilation who received ECMO support between January 2015 and December 2021. The primary outcome was 28-day in-hospital mortality. Data including demographics, comorbidities, laboratory findings, ventilator settings, and rescue therapies were analyzed. Multivariable logistic regression analysis was used to identify independent risk factors for survival. Receiver operating characteristic (ROC) curves and Kaplan-Meier survival curves were subsequently constructed to evaluate the predictive performance and compare cumulative survival rates, respectively. Results: Out of 57 eligible patients, 52 (91.2%) were included in the final analysis. The overall mortality rate was 53.8%. Successful weaning, achieved in 34 patients, correlated strongly with improved survival ( Conclusion: For pediatric patients with severe AHRF and hemodynamic compromise placed on VA-ECMO, lower pre-ECMO PaO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.